8-K
filed February 25, 2026, 6:59 PM ET
ticker RXRX
CIK 0001601830
earnings
confidence high
sentiment positive
materiality 0.75
Recursion Q4 revenue $35.5M; first AI-driven clinical validation in FAP; cash runway to 2028
RECURSION PHARMACEUTICALS, INC.
2025-FY EPS reported
-$1.44
revenue$74,681,000
- Q4 revenue $35.5M (up from $4.5M YoY); net loss $108.1M vs $178.9M; cash $753.9M.
- REC-4881 (MEK1/2) in FAP: 75% evaluable patients had reduced polyp burden at 12 weeks; 43% median reduction.
- Fifth Sanofi milestone ($4M) achieved Feb 2026; total $134M milestone payments received from Sanofi.
- 2026 cash operating expense guidance <$390M; cash runway into early 2028 without additional financing.
- REC-7735 (PI3Kα H1047R) shows >100-fold selectivity over WT; IND-enabling studies ongoing.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001601830-26-000038
- form_type
- 8-K
- ticker
- RXRX
- cik
- 0001601830
- company_name
- RECURSION PHARMACEUTICALS, INC.
- filed_at
- 2026-02-25T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:35.602473+00:00
- generated_at
- 2026-05-16T00:18:53.798793+00:00
- sec_items
- ["2.02", "7.01", "9.01"]
- event_type
- earnings
- sentiment
- positive
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001601830-26-000038
- json_url
- https://secwatch.observer/filing/0001601830-26-000038.json
- markdown_url
- https://secwatch.observer/filing/0001601830-26-000038.md
- text_url
- https://secwatch.observer/filing/0001601830-26-000038.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1601830/000160183026000038/0001601830-26-000038-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1601830/000160183026000038/rxrx-20260225.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
FNGR
FingerMotion FY2026 revenue down 32% to $24.1M; net loss widens to $7.0M
FingerMotion, Inc.
May 29, 2026, 5:12 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
ADSK
Autodesk Q1 FY27 revenue up 18% to $1.93B, GAAP EPS $2.32; acquires MaintainX
Autodesk, Inc.
May 28, 2026, 4:14 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
OKTA
Okta Q1 FY2027 rev $765M (+11% YoY); GAAP net income $74M; free cash flow $271M
Okta, Inc.
May 28, 2026, 4:03 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SOTK
Sono-Tek reports FY2026 net income up 42% to $1.8M; gross margin expands to 51%
SONO TEK CORP
May 28, 2026, 7:10 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
DLTR
Dollar Tree Q1 net sales +7.2%, comp +3.5%, adj EPS $1.74 (+38%), raises FY guidance
DOLLAR TREE, INC.
May 28, 2026, 6:31 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
BBWI
BBWI Q1 sales down 3%, adjusted EPS $0.32 beats guidance; CFO Boratto to step down June 12
Bath & Body Works, Inc.
May 27, 2026, 7:12 AM ET
earnings
Items 2.02, 7.01, 5.02, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SMTC
Semtech reports record Q1 net sales $291M, GAAP EPS $0.27, adjusted EPS $0.51
SEMTECH CORP
May 26, 2026, 4:07 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
EMAT
EMAT reports Q1 GAAP net loss of $440.3M on $425M non-cash charge; adjusted loss $15.1M
Evolution Metals & Technologies Corp.
May 22, 2026, 9:28 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.